XHKG
1970
Market cap354mUSD
Jul 09, Last price
8.20HKD
1D
0.24%
1Q
8.04%
Jan 2017
-78.42%
IPO
-77.53%
Name
IMAX China Holding Inc
Chart & Performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
As an investment holding company, IMAX China Holding, Inc. delivers cutting-edge digital and film-based motion picture technologies throughout Greater China, encompassing the People's Republic of China, Hong Kong, Macau, and Taiwan. Its operational framework is divided into three primary segments: the IMAX Technology Network, IMAX Technology Sales and Maintenance, and New Business Initiatives and Other. A primary function involves transforming both Hollywood and Chinese-language films into the immersive IMAX format via its proprietary Digital Re-Mastering (DMR) process, subsequently showcasing these productions across its extensive theatre network. Additionally, it designs, sources, and installs advanced digital theatre systems for its exhibitor partners, complemented by project management, maintenance, and comprehensive aftermarket support. Beyond core installations, the company offers technical research and development, consulting, training, and marketing services for its multimedia and theatre systems. It also handles the wholesale, import, leasing, maintenance, and repair of movie theatre equipment, photographic gear, and virtual reality display technology, alongside ongoing software and hardware development. Diversifying its portfolio, IMAX China distributes a range of consumer goods, including gifts, apparel, stationery, and electronics. It also delivers creative and conference services, business consultation, cultural exchange planning, and operates as a ticketing and publishing agent, alongside engaging in advertising design and production. Founded in 2010, IMAX China Holding, Inc. is headquartered in Shanghai, China, and operates as a subsidiary of Imax (Barbados) Holdings, Inc.
Valuation
Title USD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||